| Chronic Lymphocytic Leukemia |
1 |
1 |
| Biologic Therapy |
0 |
0.99 |
| Remission |
0 |
0.68 |
| Cancer |
0 |
0.48 |
| Tyrosine Kinase Inhibitor |
0 |
0.41 |
| Tyrosine Kinase |
0 |
0.29 |
| Stem Cell Research and Therapy |
0 |
0.25 |
| Leukemia |
0 |
0.19 |
| Residual Disease |
0 |
0.19 |
| Diarrhea |
0 |
0.15 |
| Neutropenia |
0 |
0.15 |
| Patient Safety |
0 |
0.15 |
| Adverse Effects |
0 |
0.1 |
| Drug Resistance |
0 |
0.1 |
| Europe |
0 |
0.1 |
| Lymphoma |
0 |
0.1 |
| Ohio |
0 |
0.1 |
| Texas |
0 |
0.1 |
| Transplantation |
0 |
0.1 |